News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino
Photo: Paolo Tarantino/Twitter
Jun 10, 2023, 02:53

Patients progressing on 1L palbo should not receive further exposure to palbo- Paolo Tarantino

Consistent with the PACE trial, the PALMIRA randomized phase 2 trial showed no benefit in terms of PFS or OS with the use of palbociclib beyond progression to 1L ET+palbo. Patients progressing on 1L palbo should not receive further exposure to palbo. #ASCO23

Source: Paolo Tarantino/Twitter

ASCO23 palbo palbociclib Palmira Paolo Tarantino
Special Coverage
Blog
Aug 2, 2025, 08:07
Rami Manochakian: "Era of hope" for Patients with Lung Cancer
Blog
Aug 2, 2025, 08:06
Chalothorn “Sai” Wannaphut: Racial Disparities in Non–Small Cell Lung Cancer Survival Outcomes
Blog
Aug 2, 2025, 07:52
Allison Rosen: Grateful to Contribute to QI in Peds/AYA Oncology Survivorship Care
Blog
Aug 2, 2025, 07:04
Catharine Young: Making Profound Impact on the Lives of Cancer Patients in LMICs
Blog
Aug 2, 2025, 06:54
New Drugs and the Impact of Artificial Intelligence - ESO
Blog
Aug 2, 2025, 06:37
Post-Traumatic Growth in Cancer Patients - CancerWorld
Drugs
Aug 2, 2025, 06:29
Telisotuzumab vedotin (Emrelis) Updates 2025: Uses in Cancer, Dosage, Side Effects, Expectations, and More
Oncolibrary
Aug 2, 2025, 05:52
Immigration and Cancer Outcomes: Bridging the Gap in Healthcare Access
Insight
Aug 2, 2025, 00:36
Elizabeth Smyth: Review on a Key Emerging Biomarker in Gastric and Gastroesophageal Cancer
Blog
Aug 2, 2025, 00:00
Maryam Lustberg: Discussing PCPs vs Oncologists
Blog
Aug 1, 2025, 23:23
Big Changes are Coming to How Cancer Research Gets Funded - Fight Colorectal Cancer
Insight
Aug 1, 2025, 21:18
Francesco Massari: Latest Research on Immune-Based Combinations in Non–clear Cell Renal Cell Carcinoma